Literature DB >> 18286466

Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations.

Stephen R Grobmyer1, John D Reith, Amir Shahlaee, Charles H Bush, Steven N Hochwald.   

Abstract

Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are rare tumors that often occur in patients with neurofibromatosis 1. Surgical resection represents the mainstay of treatment. Radiation and chemotherapy have a role in selected patients with MPNST. Accurate pathologic diagnosis remains a challenge in many cases of MPNST. There are many recent advances in the understanding of the molecular pathogenesis of MPNST which represent the best opportunities to develop new strategies for management of patients with MPNST. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18286466     DOI: 10.1002/jso.20971

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  52 in total

1.  Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment.

Authors:  Jilong Yang; Antti Ylipää; Yan Sun; Hong Zheng; Kexin Chen; Matti Nykter; Jonathan Trent; Nancy Ratner; Dina C Lev; Wei Zhang
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

2.  Role of ultrasonography in detection of renal artery pseudoaneurysm caused by retroperitoneal malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.

Authors:  Abhishek Jha; Prakhar Gupta; Shagufta Wahab; Gagan Gupta; Syed YasribNahid Zaidi
Journal:  J Med Ultrason (2001)       Date:  2013-06-11       Impact factor: 1.314

3.  Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.

Authors:  Jennifer LaFemina; Li-Xuan Qin; Nicole H Moraco; Cristina R Antonescu; Ryan C Fields; Aimee M Crago; Murray F Brennan; Samuel Singer
Journal:  Ann Surg Oncol       Date:  2012-08-10       Impact factor: 5.344

4.  [Chemotherapy of brain tumors in aduts].

Authors:  P Roth; M Weller
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

Review 5.  [Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?].

Authors:  G Mechtersheimer; M Renner; R Penzel; P Schirmacher
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

6.  Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.

Authors:  Matthias R Benz; Johannes Czernin; Sarah M Dry; William D Tap; Martin S Allen-Auerbach; David Elashoff; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

7.  Establishment and characterization of a novel human malignant peripheral nerve sheath tumor cell line, FMS-1, that overexpresses epidermal growth factor receptor and cyclooxygenase-2.

Authors:  Michiyuki Hakozaki; Hiroshi Hojo; Michiko Sato; Takahiro Tajino; Hitoshi Yamada; Shinichi Kikuchi; Masafumi Abe
Journal:  Virchows Arch       Date:  2009-11-18       Impact factor: 4.064

8.  Primary paraspinal malignant peripheral nerve sheath tumor.

Authors:  Kyoung-Tae Kim; Yong-Suk Park; Jeong-Taik Kwon; Young-Baeg Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-08-30

9.  Myoepithelioma within the carpal tunnel: a case report and review of the literature.

Authors:  Jonathan Cm Clark; Stuart J Galloway; Stephen M Schlicht; Ross Pv McKellar; Peter Fm Choong
Journal:  Int Semin Surg Oncol       Date:  2009-09-09

10.  Malignant peripheral nerve sheath tumor in neurobifromatosis type-1: two case reports.

Authors:  Christos Kosmas; George Tsakonas; Katerina Evgenidi; Argyris Gassiamis; Lefkothea Savva; Nikolaos Mylonakis; Athanasios Karabelis
Journal:  Cases J       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.